| UniProt ID | NR4A2_HUMAN | |
|---|---|---|
| UniProt AC | P43354 | |
| Protein Name | Nuclear receptor subfamily 4 group A member 2 | |
| Gene Name | NR4A2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 598 | |
| Subcellular Localization |
Cytoplasm. Nucleus. Mostly nuclear oxidative stress promotes cytoplasmic localization. |
|
| Protein Description | Transcriptional regulator which is important for the differentiation and maintenance of meso-diencephalic dopaminergic (mdDA) neurons during development. It is crucial for expression of a set of genes such as SLC6A3, SLC18A2, TH and DRD2 which are essential for development of mdDA neurons (By similarity).. | |
| Protein Sequence | MPCVQAQYGSSPQGASPASQSYSYHSSGEYSSDFLTPEFVKFSMDLTNTEITATTSLPSFSTFMDNYSTGYDVKPPCLYQMPLSGQQSSIKVEDIQMHNYQQHSHLPPQSEEMMPHSGSVYYKPSSPPTPTTPGFQVQHSPMWDDPGSLHNFHQNYVATTHMIEQRKTPVSRLSLFSFKQSPPGTPVSSCQMRFDGPLHVPMNPEPAGSHHVVDGQTFAVPNPIRKPASMGFPGLQIGHASQLLDTQVPSPPSRGSPSNEGLCAVCGDNAACQHYGVRTCEGCKGFFKRTVQKNAKYVCLANKNCPVDKRRRNRCQYCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSPPVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 71 | Phosphorylation | MDNYSTGYDVKPPCL HCCCCCCCCCCCCEE | 20.04 | - | |
| 91 | Sumoylation | SGQQSSIKVEDIQMH CCCCCEEEEEEEECC | 41.33 | - | |
| 125 | Phosphorylation | GSVYYKPSSPPTPTT CCEEECCCCCCCCCC | 51.85 | 17890097 | |
| 126 | Phosphorylation | SVYYKPSSPPTPTTP CEEECCCCCCCCCCC | 43.35 | 17681692 | |
| 129 | Phosphorylation | YKPSSPPTPTTPGFQ ECCCCCCCCCCCCCE | 36.33 | 17681692 | |
| 132 | Phosphorylation | SSPPTPTTPGFQVQH CCCCCCCCCCCEEEC | 23.71 | 17681692 | |
| 174 | Phosphorylation | KTPVSRLSLFSFKQS CCCCCEEEEEEECCC | 26.68 | 22210691 | |
| 177 | Phosphorylation | VSRLSLFSFKQSPPG CCEEEEEEECCCCCC | 36.51 | 29214152 | |
| 181 | Phosphorylation | SLFSFKQSPPGTPVS EEEEECCCCCCCCCC | 33.38 | 29255136 | |
| 185 | Phosphorylation | FKQSPPGTPVSSCQM ECCCCCCCCCCCCEE | 26.70 | 17681692 | |
| 226 | Ubiquitination | AVPNPIRKPASMGFP ECCCCCCCCHHCCCC | 45.73 | - | |
| 246 | Phosphorylation | HASQLLDTQVPSPPS CHHHHHCCCCCCCCC | 31.28 | 25002506 | |
| 250 | Phosphorylation | LLDTQVPSPPSRGSP HHCCCCCCCCCCCCC | 51.06 | 25850435 | |
| 253 | Phosphorylation | TQVPSPPSRGSPSNE CCCCCCCCCCCCCCC | 53.29 | 25002506 | |
| 256 | Phosphorylation | PSPPSRGSPSNEGLC CCCCCCCCCCCCCCE | 24.84 | 25850435 | |
| 258 | Phosphorylation | PPSRGSPSNEGLCAV CCCCCCCCCCCCEEC | 49.57 | 25850435 | |
| 275 | Phosphorylation | DNAACQHYGVRTCEG CCCHHHHHCCCCCCC | 7.46 | - | |
| 279 | Phosphorylation | CQHYGVRTCEGCKGF HHHHCCCCCCCCCCH | 16.71 | - | |
| 296 | Ubiquitination | RTVQKNAKYVCLANK HHHHHCCCEEEECCC | 47.84 | - | |
| 303 | Ubiquitination | KYVCLANKNCPVDKR CEEEECCCCCCCCHH | 55.08 | - | |
| 335 | Phosphorylation | MVKEVVRTDSLKGRR CEEEEEECCCCCCCC | 20.52 | 28102081 | |
| 337 | Phosphorylation | KEVVRTDSLKGRRGR EEEEECCCCCCCCCC | 31.22 | 28355574 | |
| 347 | Phosphorylation | GRRGRLPSKPKSPQE CCCCCCCCCCCCCCC | 67.21 | 16223362 | |
| 351 | Phosphorylation | RLPSKPKSPQEPSPP CCCCCCCCCCCCCCC | 40.10 | 23403867 | |
| 356 | Phosphorylation | PKSPQEPSPPSPPVS CCCCCCCCCCCCCHH | 49.00 | 25850435 | |
| 359 | Phosphorylation | PQEPSPPSPPVSLIS CCCCCCCCCCHHHHH | 45.26 | 29255136 | |
| 363 | Phosphorylation | SPPSPPVSLISALVR CCCCCCHHHHHHHHH | 26.26 | 23403867 | |
| 366 | Phosphorylation | SPPVSLISALVRAHV CCCHHHHHHHHHHHC | 22.35 | 23403867 | |
| 375 | Phosphorylation | LVRAHVDSNPAMTSL HHHHHCCCCCCCCCC | 43.56 | 23663014 | |
| 380 | Phosphorylation | VDSNPAMTSLDYSRF CCCCCCCCCCCHHHH | 28.39 | 23663014 | |
| 381 | Phosphorylation | DSNPAMTSLDYSRFQ CCCCCCCCCCHHHHH | 13.22 | 23663014 | |
| 384 | Phosphorylation | PAMTSLDYSRFQANP CCCCCCCHHHHHCCC | 13.67 | 23663014 | |
| 385 | Phosphorylation | AMTSLDYSRFQANPD CCCCCCHHHHHCCCC | 26.70 | 23663014 | |
| 530 | Ubiquitination | RVEELQNKIVNCLKD HHHHHHHHHHHHHHH | 34.76 | - | |
| 558 | Sumoylation | YLSKLLGKLPELRTL HHHHHHCCCHHHHHH | 61.92 | - | |
| 558 | Ubiquitination | YLSKLLGKLPELRTL HHHHHHCCCHHHHHH | 61.92 | - | |
| 558 | Sumoylation | YLSKLLGKLPELRTL HHHHHHCCCHHHHHH | 61.92 | - | |
| 577 | Sumoylation | LQRIFYLKLEDLVPP HHHHHEEEHHHCCCC | 38.15 | 14559918 | |
| 577 | Sumoylation | LQRIFYLKLEDLVPP HHHHHEEEHHHCCCC | 38.15 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 126 | S | Phosphorylation | Kinase | MK01 | P28482 | PhosphoELM |
| 126 | S | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
| 129 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
| 132 | T | Phosphorylation | Kinase | MK01 | P28482 | PhosphoELM |
| 132 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
| 185 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NR4A2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NR4A2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SFPQ_HUMAN | SFPQ | physical | 19144721 | |
| NCOR2_HUMAN | NCOR2 | physical | 19144721 | |
| SIN3A_HUMAN | SIN3A | physical | 19144721 | |
| SMCA4_HUMAN | SMARCA4 | physical | 17043312 | |
| SMCA2_HUMAN | SMARCA2 | physical | 17043312 | |
| RUNX1_HUMAN | RUNX1 | physical | 21468021 | |
| RXRA_HUMAN | RXRA | physical | 15604093 | |
| CSN5_HUMAN | COPS5 | physical | 15604093 | |
| RXRB_HUMAN | RXRB | physical | 15604093 | |
| TCAL5_HUMAN | TCEAL5 | physical | 20195357 | |
| BAZ1B_HUMAN | BAZ1B | physical | 20195357 | |
| RXRA_HUMAN | RXRA | physical | 7705655 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND MASSSPECTROMETRY. | |